(Q44124134)

30 November 2017

Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival (English)

1 reference

metastatic prostate carcinoma

30 November 2017

1 reference

8

1 reference

30 November 2017

John C Cheville

1

1 reference

30 November 2017

Donald Tindall

2

1 reference

30 November 2017

Christopher Boelter

3

1 reference

30 November 2017

Robert Jenkins

4

1 reference

30 November 2017

Christine M Lohse

5

1 reference

30 November 2017

V Shane Pankratz

6

1 reference

30 November 2017

Thomas J Sebo

7

1 reference

30 November 2017

Michael L Blute

9

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

95

1 reference

30 November 2017

1028-1036

1 reference

30 November 2017

5

1 reference

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

30 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

Prognostic factors in patients with advanced prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

Effect of decalcification agents on immunoreactivity of cellular antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

21 January 2018

Digital image analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

Stage D1 prostate carcinoma. The histologic appearance of nodal metastases and its relationship to survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

The dedifferentiation of metastatic prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

Histologic features of metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

Analysis of prognostic factors in men with metastatic prostate cancer. Uro-Oncology Group of Northern Alberta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Clinical study on prognosis of metastatic prostate cancer based on extent of disease on pretreatment bone scintigraphy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

The importance of prognostic factors in advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Prognostic significance of bone metastases in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Immunohistochemical diagnosis of the metastasizing prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Effects of decalcification on immunoperoxidase staining.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Cytokeratin expression in seminoma of the human testis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Prognostic significance of antigenic heterogeneity, Gleason grade, and ploidy of lymph node metastases in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Neuroendocrine differentiation and prognosis in prostatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Neuroendocrine differentiation in metastatic prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Do neuroendocrine cells in human prostate cancer express androgen receptor?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10788

7 January 2021

Identifiers

DOI

10.1002/CNCR.10788

1 reference

release_reeyeszfojhzpodqixumku5puy

30 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/reeyeszfojhzpodqixumku5puy

24 November 2022

mapped directly with Wikidata item

1 reference